Optimization of PAMAM-gold nanoparticle conjugation for gene therapy

Biomaterials

Volumn 35, Issue 5, 2014, Pages 1725-1734

  Figueroa, Elizabeth R ^a   Lin, Adam Y ^a   Yan, Jiaxi ^a   Luo, Laureen ^a   Foster, Aaron E ^b   Drezek, Rebekah A ^a  

^a Rice University   (United States)

^b Bellicum Pharmaceuticals   (United States)

Author keywords

Dendrimer; DNA; Gene therapy; Gold; Nanocomposite; Nanoparticle

Indexed keywords

CATIONIC POLYMERS; COLLOIDAL STABILITY; COMMERCIAL AVAILABILITY; LOW CYTOTOXICITIES; NON-VIRAL GENE DELIVERY; NON-VIRAL TRANSFECTIONS; SYNTHETIC PARAMETERS; TRANSFECTION EFFICIENCY;

AMINO ACIDS; BIOCOMPATIBILITY; CROSSLINKING; DENDRIMERS; DNA; GENE TRANSFER; GOLD; METAL NANOPARTICLES; NANOCOMPOSITES; NANOPARTICLES; OPTIMIZATION;

GENE THERAPY;

AMINE; AMINO ACID; CARBOXYL GROUP; DNA; GOLD NANOPARTICLE; POLYAMIDOAMINE;

ARTICLE; BREAST ADENOCARCINOMA; CARCINOMA CELL; COLLOID; CONJUGATE; CONJUGATION; CONTROLLED STUDY; CROSS LINKING; CYTOTOXICITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR STABILITY; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; REACTION OPTIMIZATION; SYNTHESIS;

DENDRIMER; DNA; GENE THERAPY; GOLD; NANOCOMPOSITE; NANOPARTICLE;

CELL LINE; DENDRIMERS; GENETIC THERAPY; GOLD; HUMANS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; SPECTROPHOTOMETRY, ULTRAVIOLET; TRANSFECTION;

EID: 84890172563     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.11.026     Document Type: Article

References (40)

1. Gascón A.R., del Pozo-Rodríguez A., Solinís M.Á. Non-viral delivery systems in gene therapy. Gene ther.-tools potential appl., InTech 2013, 3-34. F. Martin (Ed.).
2. Klinman D.M., Takeno M., Ichino M., Gu M., Yamshchikov G., Mor G., et al. DNA vaccines: safety and efficacy issues. Springer Semin Immunopathol 1997, 19:245-256.
3. Van Gaal E.V.B., van Eijk R., Oosting R.S., Kok R.J., Hennink W.E., Crommelin D.J.A., et al. How to screen non-viral gene delivery systems invitro?. JControl Release 2011, 154:218-232.
4. Hahn P., Scanlan E. Gene delivery into mammalian cells: an overview on existing approaches employed invitro and invivo. Top Curr Chem 2010, 296:1-13.
5. De Laporte L., Cruz Rea J., Shea L.D. Design of modular non-viral gene therapy vectors. Biomaterials 2006, 27:947-954.
6. Morille M., Passirani C., Vonarbourg A., Clavreul A., Benoit J.-P. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 2008, 29:3477-3496.
7. Moghimi S.M., Symonds P., Murray J.C., Hunter A.C., Debska G., Szewczyk A. Atwo-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol Ther 2005, 11:990-995.
8. Biricova V., Laznickova A. Dendrimers: analytical characterization and applications. Bioorg Chem 2009, 37:185-192.
9. Tomalia D.A., Reyna L.A., Svenson S. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem Soc Trans 2007, 35:61-67.
10. Svenson S., Tomalia D.A. Dendrimers in biomedical applications-reflections on the field. Adv Drug Deliv Rev 2012, 64:102-115.
11. Zhu J., Shi X. Dendrimer-based nanodevices for targeted drug delivery applications. JMater Chem B 2013, 1:4199.
12. Han G., Ghosh P., De M., Rotello V.M. Drug and gene delivery using gold nanoparticles. NanoBiotechnology 2007, 3:40-45.
13. Lee J.-S., Green J.J., Love K.T., Sunshine J., Langer R., Anderson D.G. Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery. Nano Lett 2009, 9:2402-2406.
14. Ghosh P.S., Kim C.-K., Han G., Forbes N.S., Rotello V.M. Efficient gene delivery vectors by tuning the surface charge density of amino acid-functionalized gold nanoparticles. ACS Nano 2008, 2:2213-2218.
15. Davis M.E., Zuckerman J.E., Choi C.H.J., Seligson D., Tolcher A., Alabi C.a., et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010, 464:1067-1070.
16. Thomas M., Klibanov A.M. Conjugation to gold nanoparticles enhances polyethylenimine's transfer of plasmid DNA into mammalian cells. Proc Natl Acad Sci U S A 2003, 100:9138-9143.
17. Kim S.T., Chompoosor A., Yeh Y.-C., Agasti S.S., Solfiell D.J., Rotello V.M. Dendronized gold nanoparticles for siRNA delivery. Small 2012, 8:3253-3256.
18. Yan X., Blacklock J., Li J., Möhwald H. One-pot synthesis of polypeptide-gold nanoconjugates for invitro gene transfection. ACS Nano 2012, 6:111-117.
19. Shan Y., Luo T., Peng C., Sheng R., Cao A., Cao X., et al. Gene delivery using dendrimer-entrapped gold nanoparticles as nonviral vectors. Biomaterials 2012, 33:3025-3035.
20. Li P., Li D., Zhang L., Li G., Wang E. Cationic lipid bilayer coated gold nanoparticles-mediated transfection of mammalian cells. Biomaterials 2008, 29:3617-3624.
21. Chen A.M., Taratula O., Wei D., Yen H.-I., Thomas T., Thomas T.J., et al. Labile catalytic packaging of DNA/siRNA: control of gold nanoparticles "out" of DNA/siRNA complexes. ACS Nano 2010, 4:3679-3688.
22. Qin W., Yang K., Tang H., Tan L., Xie Q., Ma M., et al. Improved GFP gene transfection mediated by polyamidoamine dendrimer-functionalized multi-walled carbon nanotubes with high biocompatibility. Colloids Surf B Biointerfaces 2011, 84:206-213.
23. Liu M., Chen B., Xue Y., Huang J., Zhang L., Huang S., et al. Polyamidoamine-grafted multiwalled carbon nanotubes for gene delivery: synthesis, transfection and intracellular trafficking. Bioconjug Chem 2011, 22:2237-2243.
24. Kasturirangan V., Nair B.M., Kariapper M.T.S., Lesniak W.G., Tan W., Bizimungu R., et al. Invivo toxicity evaluation of gold-dendrimer composite nanodevices with different surface charges. Nanotoxicology 2013, 7:441-451.
25. Worden J.G., Dai Q., Huo Q. Ananoparticle-dendrimer conjugate prepared from a one-step chemical coupling of monofunctional nanoparticles with a dendrimer. Chem Commun (Camb) 2006, 1536-1538.
26. De la Fuente J.M., Berry C.C. Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus. Bioconjug Chem 2005, 16:1176-1180.
27. Bartczak D., Kanaras A.G. Preparation of peptide-functionalized gold nanoparticles using one pot EDC/sulfo-NHS coupling. Langmuir 2011, 27:10119-10123.
28. Lee S., Pérez-Luna V.H. Dextran-gold nanoparticle hybrid material for biomolecule immobilization and detection. Anal Chem 2005, 77:7204-7211.
29. Lin A.Y., Lunsford J., Bear A.S., Young J.K., Eckels P., Luo L., et al. High-density sub-100-nm peptide-gold nanoparticle complexes improve vaccine presentation by dendritic cells invitro. Nanoscale Res Lett 2013, 8:72.
30. Needham C.J., Williams A.K., Chew S.A., Kasper F.K., Mikos A.G. Engineering a polymeric gene delivery vector based on poly(ethylenimine) and hyaluronic acid. Biomacromolecules 2012, 13:1429-1437.
31. Grabarek Z., Gergely J. Zero-length crosslinking procedure with the use of active esters. Anal Biochem 1990, 185:131-135.
32. Hermanson G.T. Bioconjugate techniques 2008, Academic Press. 2nd ed.
33. Jain P.K., Qian W., El-Sayed M.A. Ultrafast cooling of photoexcited electrons in gold nanoparticle-thiolated DNA conjugates involves the dissociation of the gold-thiol bond. JAm Chem Soc 2006, 128:2426-2433.
34. Tomalia D.A. The dendritic state. Mater Today 2005, 8:34-46.
35. Qian X., Peng X.-H., Ansari D.O., Yin-Goen Q., Chen G.Z., Shin D.M., et al. Invivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat Biotechnol 2008, 26:83-90.
36. Srinivasan C. Hybrid strategies for nanolithography and chemical patterning 2012, BiblioBazaar.
37. Chang H.-C., Wang L.-C. Asimple proof of Thue's theorem on circle packing 2010.
38. Reinemann C., Stoltenburg R., Strehlitz B. Investigations on the specificity of DNA aptamers binding to ethanolamine. Anal Chem 2009, 81:3973-3978.
39. Kwok A., Eggimann G.A., Reymond J.-L., Darbre T., Hollfelder F. Peptide dendrimer/lipid hybrid systems are efficient DNA transfection reagents: structure-activity relationships highlight the role of charge distribution across dendrimer generations. ACS Nano 2013, 7:4668-4682.
40. Vozza-Brown L, Fan J, Vasu S, Yu X, Wang B, Lakshmipathy U, etal. Lipofectamine™ LTX: a new transfection reagent for effective transfection of primary cells, hard-to-transfect cells and sensitive established cell lines. Invit Corp n.d.